Toll-Like Receptors and Tissue Remodeling: The Pro/Cons Recent Findings

Journal of Cellular Physiology

Volumn 231, Issue 3, 2016, Pages 531-544

  Micera, Alessandra ^a   Balzamino, Bijorn Omar ^a   Zazzo, Antonio Di ^b   Biamonte, Filippo ^c   Sica, Gigliola ^c   Bonini, Stefano ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ALLERGENICITY; AUTOIMMUNITY; B LYMPHOCYTE DIFFERENTIATION; CELL METABOLISM; EFFECTOR CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; INNATE IMMUNITY; MICROENVIRONMENT; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET CELL; TISSUE REPAIR; ANIMAL; EPITHELIUM CELL; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; EPITHELIAL CELLS; FIBROBLASTS; HOMEOSTASIS; HUMANS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84949093084     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25124     Document Type: Review

References (190)

1. Ahmed S, Maratha A, Butt AQ, Shevlin E, Miggin SM. 2013. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by AD AM15. J Immunol 190:2217-2228.
2. Akhtar M, Watson JL, Nazli A, McKay DM, Bacterial DNA. 2003. Evokes epithelial IL-8 production by a MAPK-dependent, NF-kB-independent pathway. FASEB J 17:1321-1319.
3. Akhter A, Masir N, Elyamany G, Phang KC, Mahe E, Al-Zahrani AM, Shabani-Rad MT, Stewart DA, Mansoor A. 2015. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system. J Neurooncol 121:289-296.
4. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
5. Arranz A, Gutiérrez-Cañas I, Carrión M, Juarranz Y, Pablos JL, Martínez C, Gomariz RP. 2008. VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts. Mol Immunol 45:3065-3073.
6. Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martínez C. 2008. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and T LR4. Peptides 29:948-956.
7. Barton GM, Kagan JC. 2009. A cell biological view of Toll-like receptor function: Regulation through compartmentalization. Nat Rev Immunol 9:535-542.
8. Barton GM, Kagan JC, Medzhitov R. 2006. Intracellular localization of toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7:49-56.
9. Bashir ME, Louie S, Shi HN, Nagler-Anderson C. 2004. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 172:6978-6987.
10. Becker Y. 2005. CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations-a review, hypothesis and implications. Virus Genes 30:251-266.
11. Becker Y. 2006. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33:235-252.
12. Beisswenger C, Lysenko ES, Weiser JN. 2009. Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immunol 77:2212-2220.
13. Belinda LW, Wei WX, Hanh BT, Lei LX, Bow H, Ling DJ SARM:. 2008. A novel Toll-like receptor adaptor, is functionally conserved from arthropod to human. Mol Immunol 45:1732-1742.
14. Bendelja K, Vojvoda V, Aberle N, Cepin-Bogovic J, Gagro A, Mlinaric-Galinovic G, Rabatic S. 2010. Decreased Toll-like receptor 8 expression and lower TNF-alpha synthesis in infants with acute RSV infection. Respir Res 11:143.
15. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. 2006. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24:353-389.
16. Beyer M, Bartz H, Hörner K, Doths S, Koerner-Rettberg C, Schwarze J. 2004. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J Allergy Clin Immunol 113:127-133.
17. Bonini S, Micera A, Iovieno A, Lambiase A, Bonini S. 2005. Expression of Toll-like receptors in healthy and allergic conjunctiva. Ophthalmology 112:1548-1549.
18. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D. 2005. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 52:2656-2665.
19. Broide DH. 2008. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol 121:560-572.
20. Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Bock JA, Boyce MJ, Hansel TT, Holgate S, Barnes T. 2000. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2149-2153.
21. Buwitt-Beckmann U, Heine H, Wiesmüller KH, Jung G, Brock R, Akira S, Ulmer AJ. 2006. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 281:9049-9057.
22. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. 2006. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 7:1074-1081.
23. Chen L, Wang T, Zhang JY, Zhang SF, Liu DS, Xu D, Wang X, Chen YJ, Wen FQ. 2009. Toll-like receptor 4 relates to lipopolysaccharide-induced nucus hepersecretion in rat airway. Arch Med Res 40:10-17.
24. Chiffoleau E, Heslan JM, Heslan M, Louvet C, Condamine T, Cuturi MC. 2007. TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+CD25+ T cell. Int Immunol 19:193-201.
25. Contoli M, Caramori G, Mallia P, Johnston S, Papi A. 2005. Mechanisms of respiratory virus-induced asthma exacerbations. Clin Exp Allergy 35:137-145.
26. Corr SC, O'Neill LA. 2009. Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases. J Innate Immunol 1:350-357.
27. Cyr SL, Angers I, Guillot L, Stoica-Popescu I, Lussier M, Qureshi S, Burt DS, Ward BJ. 2009. MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model. Vaccine 27:421-430.
28. Dabbagh K, Lewis DB. 2003. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opini Infect Dis 16:199-204.
29. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. 2004. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 5:337-343.
30. Du Q, Zhou LF, Chen Z, Gu XY, Huang M, Yin KS. 2009. Imiquimod a Toll-like receptor 7 ligand, inhibits airway remodeling in a murine model of chronic asthma. Clin Exp Pharmacol Physiol. 36:43-48.
31. Ebihara N, Yamagami S, Chen L, Tokura T, Iwatsu M, Ushio H, Murakami A. 2007. Expression and function of Toll-like Receptor-3 and -9 in Human Corneal Myofibroblasts. Invest Ophthalmol Vis Sci 48:3069-3076.
32. Ebihara N, Ohtomo K, Tokura T, Ushio H, Murakami A. 2011. Effect of tacrolimus on chemokine production by corneal myofibroblasts via toll-like receptors, compared with cyclosporine and dexamethasone. Cornea 30:702-708.
33. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196:1645-1651.
34. Elass E, Aubry L, Masson M, Denys A, Guérardel Y, Maes E, Legrand D, Mazurier J, Kremer L. 2005. Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism. Infect Immun 73:7064-7068.
35. Erridge C, Duncan SH, Bereswill S, Heimesaat MM. 2010. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS ONE 5:e9125.
36. Ewaschuk JB, Backer JL, Churchill TA, Obermeier F, Krause DO, Madsen KL. 2007. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun 75:2572-2579.
37. Fang F, Ooka K, Sun X, Shah R, Bhattacharyya S, Wei J, Varga J. 2013. A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling. J Immunol 191:2966-2956.
38. Fischer SF, Rehm M, Bauer A, Höfling F, Kirschnek S, Rutz M, Bauer S, Wagner H, Häcker G. 2005. Toll-like receptor 9 signaling can sensitize fibroblasts for apoptosis. Immunol Lett 97:122-115.
39. Friedman SL. 2007. A deer in the headlights: Bambi meets liver fibrosis. Nat Med 13:1282-1281.
40. Fukushima A. 2007. Roles of T-cells in the development of allergic conjunctival diseases. Cornea 26:S40-S36.
41. Gäbele E, Mühlbauer M, Dorn C, Weiss TS, Froh M, Schnabl B, Wiest R, Schölmerich J, Obermeier F, Hellerbrand C. 2008. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem Biophys Res Commun 376:276-271.
42. Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. 2008. The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59:359-343.
43. Gelfand EW. 2009. Pediatric asthma: A different disease. Proc Am Thorac Soc 6:282-278.
44. Graham JE, Moore JE, Jiru X, Moore JE, Goodall EA, Dooley JS, Hayes VE, Dartt DA, Downes CS, Moore TC. 2007. Ocular pathogen or commensal: A PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci 48:5623-5616.
45. Grela F, Aumeunier A, Bardel E, Van LP, Bourgeois E, Vanoirbeek J, Leite-de-Moraes M, Schneider E, Dy M, Herbelin A, Thieblemont N The. 2011. TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. J Immunol 186:290-284.
46. Grissell TV, Chang AB, Gibson PG. 2007. Reduced toll-like receptor 4 and substance P gene expression is associated with airway bacterial colonization in children. Pediatr Pulmonol 42:385-380.
47. Gutiérrez-Cañas I, Juarranz Y, Santiago B, Arranz A, Martinez C, Galindo M, Payá M, Gomariz RP, Pablos JL. 2006. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford) 45:532-527.
48. Häcker G, Redecke V, Häcker H. 2002. Activation of the immune system by bacterial CpG-DNA. Immunology 105:251-245.
49. Han J, Ulevitch RJ. 2005. Limiting inflammatory responses during activation of innate immunity. Nat Immunol 6:1205-1198.
50. Hansel TT, Barnes PJ. 2009. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet 374:755-744.
51. Harzenetter MD, Novotny AR, Gais P, Molina CA, Altmayr F, Holzmann B. 2007. Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER. J Immunol 179:615-607.
52. Hasan UA, Trinchieri G, Vlach J. 2005. Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts. J Biol Chem 280:20627-20620.
53. Hasan M, Lopez-Herrera G, Blomberg KE, Lindvall JM, Berglöf A, Smith CI, Vargas L. 2008. Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice. Immunology 123:249-239.
54. Hayashi EA, Akira S, Nobrega A. 2005. Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by T LR2. J Immunol 174:6647-6639.
55. Hazeki K, Uehara M, Nigorikawa K, Hazeki O. 2013. PIK five regulates the endosomal localization of CpG oligodeoxynucleotides to elicit TLR9-dependent cellular responses. PLoS ONE 9:e73894.
56. He Z, Zhu Y, Jiang H. 2009. Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-akt pathway in fibroblasts during acute lung injury. J Recept Signal Transduct Res 29:125-119.
57. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. 2007. The myofibroblast: One function, multiple origins. Am J Pathol 170:18016-18007.
58. Hollingsworth JW, 2nd, Cook DN, Brass DM, Walker JK, Morgan DL, Foster WM, Schwartz DA. 2004. The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 170:132-126.
59. Horner AA. 2006. Update on toll-like receptor ligands and allergy: Implications for immunotherapy. Curr Allergy Asthma Rep 6:401-395.
60. Horst OV, Tompkins KA, Coats SR, Braham PH, Darveau RP, Dale BA. 2009. TGF-beta1 Inhibits TLR-mediated odontoblast responses to oral bacteria. J Dent Res 88:338-333.
61. Huang X, Du W, Barrett RP, Hazlett LD. 2007. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 48:4633-4626.
62. Hussain I, Kline JN. 2004. DNA, the immune system, and atopic disease. J Investig Dermatol Symp Proc 9:28-23.
63. Iovieno A, Lambiase A, Sacchetti M, Stampachiacchiere B, Micera A, Bonini S. 2008. Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmology 246:441-435.
64. Ishii KJ, Coban C, Akira S. 2005. Manifold mechanisms of Toll-like receptor-ligand recognition. J Clin Immunol 25:521-511.
65. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:678-674.
66. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:995-987.
67. Jesic S, Jotic A, Tomanovic N, Zivkovic M. 2014. Expression of toll-like receptors 2, 4 and nuclear factor kB in mucosal lesions of human otitis: pattern and relationship in a clinical immunohistochemical study. Ann Otol Rhinol Laryngol 123:434-441.
68. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1179-1173.
69. Jiang H, Wang PZ, Zhang Y, Xu Z, Sun L, Wang LM, Huang CX, Lian JQ, Jia ZS, Li ZD, Bai XF. 2008. Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology 380:59-52.
70. Jiang Y, Chen G, Zheng Y, Lu L, Wu C, Zhang Y, Liu Q, Cao X. 2008. TLR4 signaling induces functional nerve growth factor receptor p75NTR on mouse dendritic cells via p38MAPK and NF-kB pathways. Mol Immunol 45:1566-1557.
71. Johannsen H, Prescott SL. 2009. Practical prebiotics, probiotics and synbiotics for allergists: How useful are they? Clin Exp Allergy 39:1814-1801.
72. Johnson AC, Heinzel FP, Diaconu E, Sun Y, Hise AG, Golenbock D, Lass JH, Pearlman E. 2005. Activation of toll-like receptor (TLR) 2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci 46:595-589.
73. Jung DY, Lee H, Jung BY, Ock J, Lee MS, Lee WH, Suk K. 2005. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J Immunol 174:6476-6467.
74. Kandimalla ER, Zhu FG, Bhagat L, Yu D, Agrawal S. 2003. Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs. Biochem Soc Trans 31:658-654.
75. Kawai T, Akira S. 2007. Signaling to NF-kB by Toll-like receptors. Trends Mol Med 13:469-460.
76. Kippenberger S, Müller J, Schultz M, Dorn A, Bock A, Aygün H, Thaçi D, Hofmann M, Kaufmann R, Bernd A. 2009. Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes. Nucl Acids Res 37:3864-3850.
77. Kline JN, Krieg AM. 2008. Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy. Drug News Perspect. 21:439-434.
78. Kluwe J, Mencin A, Schwabe RF. 2009. Toll-like receptors, wound healing, and carcinogenesis. J Mol Med 87:138-125.
79. Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y. 2009. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 160:304-297.
80. Koff JL, Shao MX, Kim S, Ueki IF, Nadel JA. 2006. Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J Immunol 177:8700-8693.
81. Krieg AM. 2007. Anti-infective applications of toll-like receptor 9 agonists. Proc Am Thorac Soc 4:294-289.
82. Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT. 2004. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 173:7258-7249.
83. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. 2004. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114:182-174.
84. Kumagai N, Fukuda K, Fujitsu Y, Lu Y, Chikamoto N, Nishida T. 2005. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci 46:120-114.
85. Kumar H, Koyama S, Ishii KJ, Kawai T, Akira S. 2008. Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 180:687-683.
86. Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388:625-621.
87. Kyburz D, Rethage J, Seibi R, Lauener R, Gay RE, Carson CA, Gay S. 2003. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheumatol 48:650-642.
88. Lambiase A, Normando EM, Vitiello L, Micera A, Sacchetti M, Perrella E, Racioppi L, Bonini S, Bonini S. 2007. Natural killer cells in vernal keratoconjunctivitis. Mol Vis 13:1567-1562.
89. Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, Branca MF, Dubowski TD, Sodhi CP, Hackam DJ. 2007. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 179:4808-4820.
90. Lee KM, Seong SY. 2009. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern. Immunol Lett 125:39-31.
91. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff M, Eckmann L, Ben-Neriah Y, Raz E. 2006. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8:1336-1327.
92. Lim EJ, Lee SH, Lee JC, Chin BR, Bae YS, Kim JR, Lee CH, Baek SH. 2006. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling. FEBS Lett 580:4538-4533.
93. Liu X, Zhang Y, Yu Y, Yang X, Cao X. 2008. SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-beta1/Smad3 signaling. Mol Immunol 45:1413-1405.
94. Lorenz E, Chemotti DC, Jiang AL, McDougal LD. 2005. Differential involvement of toll-like receptors 2 and 4 in the host response to acute respiratory infections with wild-type and mutant Haemophilus influenzae strains. Infect Immunol 73:2082-2075.
95. Loryman C, Mansbridge J. 2008. Inhibition of keratinocyte migration by lipopolysaccharide. Wound Repair Regen 16:51-45.
96. Lugo-Villarino G, Ito S, Klinman DM, Glimcher LH. 2005. The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells. Proc Nat Acad Sci USA 102:13253-13248.
97. Lukacs NW, Smit JJ, Mukherjee S, Morris S, Nunez G, Lindell DM. 2010. Respiratory virus-induced TLR7 activation controls IL17 associated increased mucus via IL23 regulation. J Immunol 185:2239-2231.
98. Månsson A, Cardell LO. 2009. Role of atopic status in Toll-like receptor (TLR) 7- and TLR9-mediated activation of human eosinophils. Leukocytes Biol 85:727-719.
99. Månsson A, Fransson M, Adner M, Benson M, Uddman R, Björnsson S, Cardell LO. 2010. TLR3 in human eosinophils: functional effects and decreased expression during allergic rhinitis. Int Arch Allergy Immunol 151:128-118.
100. Macedo L, Pinhal-Enfield G, Alshits V, Elson G, Cronstein BN, Leibovich SJ. 2007. Wound healing is impaired in MyD88-deficient mice A role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 171:1774-1788.
101. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O'Neill LA, Hertzog PJ. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 7:155-148.
102. Mantelli F, Micera A, Sacchetti M, Bonini S. 2010. Neurogenic inflammation of the ocular surface. Br J Ophthalmol 94:956-957.
103. Matsumoto M, Seya T. 2008. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 60:805-812.
104. Melchjorsen J, Risør MW, Søgaard OS, O'Loughlin KL, Chow S, Paludan SR, Ellermann-Eriksen S, Hedley DW, Minderman H, Østergaard L, Tolstrup M. 2011. Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cells. J Acquir Immune Defic Syndr 57:275-265.
105. Mellett M, Atzei P, Jackson R, O'Neill LA, Moynagh PN. 2011. Mal mediates TLR-induced activation of CREB and expression of IL-10. J Immunol 186:4935-4925.
106. Meneghin A, Hogaboam CM. 2007. Infectious disease, the innate immune response, and fibrosis. J Clin Invest 117:538-530.
107. Meyer-Bahlburg A, Khim S, Rawlings DJ. 2007. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med 20:3101-3095.
108. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, Tschopp J. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kB activation. Nat Immunol 5:507-503.
109. Meyts I, Hellings PW, Hens G, Vanaudenaerde BM, Verbinnen B, Heremans H, Matthys P, Bullens DM, Overbergh L, Mathieu C, De Boeck K, Ceuppens JL. 2006. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 177:6470-6460.
110. Micera A, Lambiase A, Puxeddu I, Aloe L, Stampachiacchiere B, Levi-Schaffer F, Bonini S, Bonini S. 2006. Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing. Exp Eye Res 83:757-747.
111. Micera A, Lambiase A, Bonini S. 2008. The role of neuromediators in ocular allergy. Curr Opin Allergy Clin Immunol 8:471-466.
112. Micera A, Stampachiacchiere B, Normando EM, Lambiase A, Bonini S, Bonini S. 2009. Nerve growth factor modulates toll-like receptor (TLR) 4 and 9 expression in cultured primary VKC conjunctival epithelial cells. Mol Vis 13:2044-2037.
113. Miller A, Iovieno A. 2009. The role of microflora on the ocular surface. Curr Opin Allergy Clin Immunol 9:470-466.
114. Miyake Y, Sasaki S, Yokoyama T, Chida K, Azuma A, Suda T, Kudoh S, Sakamoto N, Okamoto K, Kobashi G, Washio M, Inaba Y, Tanaka H. 2006. Japan Idiopathic Pulmonary Fibrosis Study Group. Dietary fat and meat intake and idiopathic pulmonary fibrosis: a case-control study in Japan. Int J Tuberc Lung Dis 10:339-333.
115. Moali C, Hulmes DJ. 2009. Extracellular and cell surface proteases in wound healing: new players are still emerging. Eur J Dermatol 19:564-552.
116. Moisan J, Camateros P, Thuraisingam T, Marion D, Koohsari H, Martin P, Boghdady ML, Ding A, Gaestel M, Guiot MC, Martin JG, Radzioch D. 2006. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol 290:L995-L987.
117. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, Tripp RA, Kurt-Jones EA, Finberg RW. 2009. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 83:1500-1492.
118. Nigo YI, Yamashita M, Hirahara K, Shinnakasu R, Inami M, Kimura M, Hasegawa A, Kohno Y, Nakayama T. 2006. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Nat Acad Sci USA 103:2291-2286.
119. O'Neill LA. 2008. 'Fine tuning' TLR signaling. Nat Immunol 9:61-459.
120. Obermeier F, Dunger N, Strauch UG, Hofmann C, Bleich A, Grunwald N, Hedrich HJ, Aschenbrenner E, Schlegelberger B, Rogler G, Schölmerich J, Falk W. 2005. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology 129:913-927.
121. Okazaki N, Hazeki K, Izumi T, Nigorikawa K, Hazeki O. 2011. C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase. J Biochem (Tokyo) 149:274-265.
122. Okugawa S, Yanagimoto S, Tsukada K, Kitazawa T, Koike K, Kimura S, Nagase H, Hirai K, Ota Y. 2006. Bacterial flagellin inhibits T cell receptor-mediated activation of T cells by inducing suppressor of cytokine signalling-1 (SOCS-1). Cell Microbiol 8:1580-1571.
123. Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D. 2008. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheumatol 58:3692-3684.
124. Packard KA, Khan MM. 2003. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol 3:920-909.
125. Page K, Hughes VS, Odoms KK, Dunsmore KE, Hershenson MB. 2005. German cockroach proteases regulate interleukin-8 expression via nuclear factor for interleukin-6 in human bronchial epithelial cells. Am J Respir Cell Mol Biol 32:231-225.
126. Pandey S, Agrawal DK. 2006. Immunobiology of Toll-like receptors: Emerging trends. Immunol Cell Biol 84:341-333.
127. Pasare C, Medzhitov R. 2005. Control of B-cell responses by Toll-like receptors. Nature 438:368-364.
128. Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson NC, Liew FY. 2005. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 174:7563-7558.
129. Pearlman E, Johnson A, Adhikary G, Sun Y, Chinnery HR, Fox T, Kester M, McMenamin PG. 2008. Toll-like receptors at the ocular surface. Ocul Surf 6:116-108.
130. Pei Z, Lin D, Song X, Li H, Yao H. 2008. TLR4 signaling promotes the expression of VEGF and TGFβ1 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol 254:27-20.
131. Piccinini AM, Midwood KS. 2010. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm.
132. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Saizman AL, Boons GL, Leibovich SJ. 2003. An angiogenic switch in macrophages involving synergy between Toll like receptors 2, 4, 7 and 9 and adenosine A(2A) receptors. Am J Pathol 163:721-711.
133. Pinto LA, Dias AC, Rymer BL, Fernandes FF, Barbosa GL, Machado DC, Jones MH, Teixeira CG, Stein RT, Pitrez PM. 2006. Effect of Angiostrongylus costaricensis extract on eosinophilic pulmonary response in BALB/c mice. Parasitol Res 98:298-295.
134. Platz J, Beisswenger C, Dalpke A, Koczulla R, Pinkenburg O, Vogelmeier C, Bals R. 2004. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J Immunol 173:1223-1219.
135. Prod'homme T, Weber MS, Steinman L, Zamvil SS. 2006. A neuropeptide in immune-mediated inflammation, Y? Trends Immunol 27:167-164.
136. Punturieri A, Alviani RS, Polak T, Copper P, Sonstein J, Curtis JL. 2004. Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. J Immunol 173:1042-1033.
137. Redecke V, Häcker H, Datta SK, Fermin A, Pitha PM, Broide DH, Raz E. 2004. Cutting edge: Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172:2743-2739.
138. Ren MY, Wu XY. 2011. Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba Keratitis. Parasite Immunol 33:33-25.
139. Revets H, Pynaert G, Grooten J, De Baetselier P, Lipoprotein I. 2005. A TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol 174:1103-1097.
140. Rezania S, Amirmozaffari N, Rashidi N, Mirzadegan E, Zarei S, Ghasemi J, Zarei O, Katouzian L, Zarnani AH. 2014. The same and not the same: Heterogeneous functional activation of prostate tumor cells by TLR ligation. Cancer Cell Int 14:54.
141. Rodriguez N, Wantia N, Fend F, Dürr S, Wagner H, Miethke T. 2006. Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae. Eur J Immunol 36:1155-1145.
142. Rogers GL, Suzuki M, Zolotukhin I, Markusic DM, Morel LM, Lee B, Ertl HC, Herzog RW. 2015. Unique roles of TLR9- and MyD88-dependent and -independent pathways in adaptive immune responses to AAV-mediated gene transfer. J Innate Immun 7:314-302.
143. Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA, Gruber A, Berlin AA, Lukacs NW. 2006. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 176:1942-1937.
144. Sarangi PP, Kim B, Kurt-Jones E, Rouse BT. 2007. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: Role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 81:11138-11128.
145. Sato A, Linehan MM, Iwasaki A. 2006. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Nat Acad Sci USA 103:17348-17343.
146. Schnetzke U, Spies-Weisshart B, Yomade O, Fischer M, Rachow T, Schrenk K, Glaser A, von Lilienfeld-Toal M, Hochhaus A, Scholl S. 2015. Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia. Genes Immun 16:88-83.
147. Schröder NW, Arditi M. 2007. The role of innate immunity in the pathogenesis of asthma: evidence for the involvement of Toll-like receptor signaling. J Endotoxin Res 13:312-305.
148. Schröder NW, Maurer M. 2007. The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 62:590-579.
149. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. 2007. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324-1332.
150. Sel S, Wegmann M, Sel S, Bauer S, Garn H, Alber G, Renz H. 2007. Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol 178:7813-7805.
151. Sgrulletta R, Bonini S, Lambiase A, Bonini S. 2006. Allergy and infections: long-term improvement of vernal keratoconjunctivitis following viral conjunctivitis. Eur J Ophthalmol 16:473-470.
152. Shaykhiev R, Behr J, Bals R. 2008. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS ONE 3:1393-139e.
153. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I. 2003. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108:2910-2905.
154. Soule BP, Brown JM, Kushnir-Sukhov NM, Simone NL, Mitchell JB, Metcalfe DD. 2007. Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J Immunol 179:3286-3276.
155. Steinman L. 2004. Elaborate interactions between the immune and nervous systems. Nat Immunol 5:581-575.
156. Sugiura H, Ichikawa T, Koarai A, Yanagisawa S, Minakata Y, Matsunaga K, Hirano T, Akamatsu K, Ichinose M. 2009. Activation of Toll-like receptor 3 augments myofibroblast differentiation. Am J Respir Cell Mol Biol 40:662-654.
157. Takeda K, Akira S. 2004. Microbial recognition by Toll-like receptors. J Dermatol Sci 34:82-73.
158. Talreja J, Kabir MH, Filla B, Stechschulte M, Dileepan DJ. 2004. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 113:233-224.
159. Tang C, Inman MD, van Rooijen N, Yang P, Shen H, Matsumoto K, O'Byrne PM. 2001. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 166:1481-1471.
160. Trinchieri G, Sher A. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7:190-179.
161. Tross D, Petrenko L, Klaschik S, Zhu Q, Klinman DM. 2009. Global changes in gene expression and synergistic interactions induced by TLR9 and T LR3. Mol Immunol 46:2564-2557.
162. Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG. 2007. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 179:140-132.
163. Tulic MK, Christodoulopoulos P, Fiset PO, Vaillancourt P, Lavigne F, Marshall JD, Van Nest G, Eiden JJ, Hamid Q. 2009. Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects. Allergol Int 58:572-565.
164. Ueta M, Kinoshita S. 2010. Ocular surface inflammation mediated by innate immunity. Eye Contact Lens 36:269-281.
165. Ueta M, Nochi T, Jang MH, Park EJ, Igarashi O, Hino A, Kawasaki S, Shikina T, Hiroi T, Kinoshita S, Kiyono H. 2004. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol 173:3347-3337.
166. Ueta M, Hamuro J, Kiyono H, Kinoshita S. 2005. Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun 331:294-285.
167. Ueta M. 2008. Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea 27:S31-S40.
168. Umetsu DT, Dekruyff RH. 2010. The regulatory role of natural killer T cells in the airways. Int J Biochem Cell Biol 42:534-529.
169. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. 2008. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Nat Acad Sci USA 105:20863-20858.
170. van Rijt LS, van Kessel CH, Boogaard I, Lambrecht BN. 2005. Respiratory viral infections and asthma pathogenesis: A critical role for dendritic cells? J Clin Virol 34:161-169.
171. Vaure C, Liu Y. 2014. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol 10:316.
172. Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A. 2009. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kB proinflammatory responses. J Biol Chem 284:24203-24192.
173. Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS. 2006. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol 169:1700-1686.
174. Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM. 2004. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113:223-212.
175. Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, Tuma E, Giese T, Ellwart JW, Endres S, Hartmann G. 2004. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol 172:963-954.
176. Wagner H. 1999. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol 73:368-329.
177. Wakefield D, Gray P, Chang J, Di Girolamo N, McCluskey P. 2010. The role of PAMP's and DAMP's in the pathogenesis of acute and recurrent anterior uveitis. Br J Ophthalmol 94:274-271.
178. Walter K, Hölscher C, Tschopp J, Ehlers S. 2010. NALP3 is not necessary for early protection against experimental tuberculosis. Immunobiology 215:811-804.
179. Wang G, Liu CT, Wang ZL, Jiang LL, Yan CL, Luo FM. 2006. Antisense oligonucleotides-induced local blockade of T-bet expression leads to airway inflammation in rats. Acta Pharmacol Sin 27:567-561.
180. Wang LC, Lee JH, Yang YH, Lin YT, Chiang BL. 2007. New biological approaches in asthma: DNA-based therapy. Curr Med Chem 14:1618-1607.
181. Wong Y, Sethu C, Louafi F, Hossain P. 2011. Lipopolysaccharide regulation of Toll-Like Receptor-4 and Matrix Metalloprotease-9 in human primary corneal fibroblast cells. Invest Ophthalmol Vis Sci 52:2803-2796.
182. Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, Lancaster LH, Wolters PJ, DeRisi J, Ganem D, Collard HR. 2011. Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:1702-1698.
183. Wynn TA. 2007. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:529-524.
184. Wynn TA. 2008. Cellular and molecular mechanisms of fibrosis. J Pathol 214:210-199.
185. Xin BM, Wang XX, Jin W, Yan HM, Cui B, Zhang XW, Hu HZ. 2010. Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis. Acta Pharmacol Sin 31:1692-1583.
186. Yang IA, Fong KM, Holgate ST, Holloway JW. 2006. The role of 1 Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 6:28-23.
187. Yi AK, Krieg AM. 1998. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kB alpha and I kB beta and sustained activation of nuclear factor-kB/c-Rel. J Immunol 160:1245-1240.
188. Youn CJ, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, McElwain K, McElwain S, Raz E, Broide DH. 2004. Immunostimulatory DNA reverses established allergen-induced airway remodeling. J Immunol 173:7564-7556.
189. Zhang Z, Goldberg DJ, Wilson JB. 2005. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect Immun 73:7160-7151.
190. Zhang L, Hui W, Litherland GJ, Barter MJ, Davidson R, Darrah C, Donell ST, Clark IM, Cawston TE, Robinson JH, Rowan AD, Young DA. 2008. Differential Toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis 67:1641-1633.